Financial Analyst jobs

Biotech Investment Analyst - Drug Asset & Company Assessment

Weekday AIRemote · US onlyContractPosted 2 months ago

$120–$200/hr listed by the employer

Key facts

Pay per year
≈ $250k–$416kEstimate for full-time hours.

This job is closed.

The employer took it down 19 days ago, after 2 days open. Here are similar open jobs.

  • Checked: On the company's own careers siteWorkable board
  • Checked: Pay range listedJob posting
  • Checked: No reposts foundWorkable board
  • Trust score 89 / 100 · Looks good
See all 4 checksShow fewer
How we check

Similar open jobs

Financial Analyst

Cogstate · Remote · US only

$100k–$110k/yr

StrongChecked open todayPosted 11 days ago

Financial Analyst II

Cherokee Federal · Remote · US only

$100k–$104k/yr

StrongChecked open todayPosted 1 month ago

Pricing Analyst

Cohere Health · Remote · US only

$75k–$90k/yr

StrongChecked open todayPosted 1 month ago

FP&A Analyst

Stratolaunch · Remote · US only

$82k–$158k/yr

StrongChecked open todayPosted 1 month ago

Financial Analyst

Seso Inc., · Remote · US only

StrongPay not listedChecked open todayPosted 18 days ago

FP&A Analyst

Nimble Gravity · Remote · location not stated

StrongPay not listedChecked open todayPosted 19 days ago

See more like this

What you’ll do

  • Create and critique rubrics for analyzing commercial drugs and drug-development programs.
  • Assess companies and assets, including mechanism, clinical data, competitive position, and value drivers.
  • Evaluate investment-style theses and flag weak, overconfident, or missing assumptions.
  • Apply assessments across approximately 5–10 companies.

Summarised from the posting by AI and can be wrong. The full description is the source.

Requirements

Experience

  • US-based biotech/healthcare investment analyst with a specialist-fund background
  • Familiarity with biotech/pharma development programs
  • 5+ years evaluating biotech/pharma companies or assets

Skills

  • Ability to assess a drug asset and the company behind it end-to-end

Full job description

From Weekday AI’s careers site

This role is for one of our clients

Compensation: $120 - $200 per hour

We are partnering with a biotech and pharma research team on expert human-evaluation work — creating and critiquing rubrics that analyze commercial drugs and drug-development programs. We're seeking a biotech investment analyst (specialist-fund background) for a paid pilot, with the potential to continue as the work scales.

Requirements

Responsibilities

  • Create and critique rubrics that analyze commercial drugs and drug-development programs
  • Provide overall company and asset assessment — mechanism, clinical data, competitive position, and value drivers
Show full descriptionShow less
  • Judge the quality of an investment-style thesis and flag weak, overconfident, or missing assumptions
  • Apply your assessment across the pilot's set of companies (~5–10)

Requirements

  • US-based biotech / healthcare investment analyst with a specialist-fund background
  • Familiarity with biotech/pharma development programs
  • Able to assess a drug asset and the company behind it end-to-end
  • 5+ years evaluating biotech/pharma companies or assets

Engagement Details

  • Duration: Approximately 10–20 hours over a 1–2 week pilot
  • Remote — US-based

Why Participate

  • Help improve expert AI evaluation of drugs and drug-development programs
  • Recurring engagement for strong contributors

We consider all qualified applicants without regard to legally protected characteristics and provide reasonable accommodations upon request.

Something wrong with this job? Report it · This flag looks wrong